We are a consumer healthcare products brand focused on Pain management. We offer convenience and choice through innovative over-the-counter products in the form of Transdermal Patches, Therapeutic Oils and Nutraceuticals.
Our flagship product helps in fast and long-lasting relief from knee pain and stiffness. Our unique advanced formula contains AKBA which makes it highly effective and provides long lasting relief. Our Quick-abosrb Technology ensures that the oil starts penetrating into the skin within 26 seconds thus providing fast relief. We have identified, isolated and standardized AKBA to a level where it is highly effective and this intellectual property is unique to us. Further, while most competition is focused on back pain, Rhuval Oil is positioned as a specialist for knee pain.
Our Product is targeted at chronic patients of knee pain, we have transdermal patches for relief from acute musculoskeletal pain especially the upper back, targeted at people with sedentary lifestyle. Viopatch herbal transdermal patches provide sustained relief for 12 hours from musculoskeletal pain.
Our pain management solutions address topical pain management market which clocked INR 3380 crores in 2018 and is growing at 17-20% yoy. We aim to achieve leadership in target segments through innovation, technology, product performance and unique positioning.
We are a recognised leader in selling through pharma Modern Trade channel. Post Covid lockdown, we have pivoted to online sales as retail channel is restricted in the short term. Our sales revenue mix is now 22% online, a significant jump from <5% pre-covid. We further aim to change this mix in the favour of online with a contribution of 50-70% to our top-line.
To expand our pain management portfolio, we have developed a unique proposition for relief from menstrual cramps. This product is launch ready and has been developed and patented in the US. This will help us reach out to women consumers at an early age and hold them through the lifecycle.
INR 2 Cr
I do not have any investment commitment
Industry & Sub-Industry
Health and Pharma (1)
End use of fund (in %)
|Is your Technology Patented||No|
|How will you leverage technology in your business?||We have pivoted from retail to online and aiming for 50-70% contribution from online sales.|
|2017 (in Cr)||2018 (in Cr)||2019 (in Cr)||2020 (in Cr)|
|Sales||N.D||N.D||INR 2.3 Cr||INR 6.8 Cr|